Log in to save to my catalogue

Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to imm...

Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to imm...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_63c7a6b15ee74a9d819e44b8f20fa851

Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma

About this item

Full title

Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-08, Vol.11 (1), p.16732-16732, Article 16732

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Comprehensive analysis of clinical samples has recently identified molecular and immunological classification of hepatocellular carcinoma (HCC), and the
CTNNB1
(β-catenin)-mutated subtype exhibits distinctive characteristics of immunosuppressive tumor microenvironment. For clarifying the molecular mechanisms, we first established human and mo...

Alternative Titles

Full title

Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_63c7a6b15ee74a9d819e44b8f20fa851

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_63c7a6b15ee74a9d819e44b8f20fa851

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-96167-0

How to access this item